|Faculty / Departement
|Register by Units||Register by Projects||Register of researchers|
|Register by Collaborations||Ranking by Domains||Ranking by Frascati||Disciplines CREF|
Units : ULB Center for Diabetes Research | ULB218
We are utilizing modern molecular biological tools, such as microarray analysis and detailed studies of promoter regulation, to unveil the genes and transcription factors regulating the decision of the beta cells to undergo apoptosis in early diabetes mellitus and following islet transplantation. Based on this information, we search for novel therapies for the disease.
• Fonds associés (toutes subventions, y compris la Loterie Nat.)
• Actions concertées
• Autres U.E.
• Financement de base institutionnel